Vertex Pharmaceuticals Incorporated (ETR:VX1)
Germany
· Delayed Price · Currency is EUR 391.85
+0.45 (0.11%)
May 13, 2025, 5:35 PM CET
Vertex Pharmaceuticals Market Cap
Vertex Pharmaceuticals has a market cap or net worth of €101.47 billion as of May 13, 2025. Its market cap has increased by 5.44% in one year.
Market Cap
101.47B
Enterprise Value
92.74B
Revenue
10.27B
Ranking
n/a
PE Ratio
n/a
Stock Price
€391.85
Market Cap Chart
Since July 24, 1991, Vertex Pharmaceuticals's market cap has increased from 73.88M to 101.47B, an increase of 137,234.16%. That is a compound annual growth rate of 23.81%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 53.63B |
| Siemens Healthineers AG | 52.53B |
| Fresenius SE & Co. KGaA | 24.31B |
| Bayer Aktiengesellschaft | 23.62B |
| Fresenius Medical Care AG | 14.91B |
| Sartorius Aktiengesellschaft | 14.38B |
| Carl Zeiss Meditec AG | 5.30B |
| Fielmann Group AG | 4.54B |